Cargando…
Overestimation of grey matter atrophy in glioblastoma patients following radio(chemo)therapy
OBJECTIVE: Brain atrophy has the potential to become a biomarker for severity of radiation-induced side-effects. Particularly brain tumour patients can show great MRI signal changes over time caused by e.g. oedema, tumour progress or necrosis. The goal of this study was to investigate if such change...
Autores principales: | Gommlich, A., Raschke, F., Petr, J., Seidlitz, A., Jentsch, C., Platzek, I., van den Hoff, J., Kotzerke, J., Beuthien-Baumann, B., Baumann, M., Krause, M., Troost, E. G. C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8901471/ https://www.ncbi.nlm.nih.gov/pubmed/33786695 http://dx.doi.org/10.1007/s10334-021-00922-3 |
Ejemplares similares
-
Time- and dose-dependent volume decreases in subcortical grey matter structures of glioma patients after radio(chemo)therapy
por: Raschke, F., et al.
Publicado: (2022) -
Retrospective assessment of MRI-based volumetric changes of normal tissues in glioma patients following radio(chemo)therapy
por: Gommlich, Andreas, et al.
Publicado: (2017) -
Quantitative accuracy of attenuation correction in the Philips Ingenuity TF whole-body PET/MR system: a direct comparison with transmission-based attenuation correction
por: Schramm, Georg, et al.
Publicado: (2012) -
Erratum to: Quantitative accuracy of attenuation correction in the Philips Ingenuity TF whole-body PET/MR system: a direct comparison with transmission-based attenuation correction
por: Schramm, Georg, et al.
Publicado: (2014) -
PET/MRI Imaging in High-Risk Sarcoma: First Findings and Solving Clinical Problems
por: Schuler, Markus K., et al.
Publicado: (2013)